-
1.AMINOPYRIMIDINE COMPOUNDS AS INHIBITORS OF T790M CONTAINING EGFR MUTANTS 有权
Title translation: 作为含有EGFR突变体的T790M的抑制剂的氨基嘧啶化合物公开(公告)号:US20160016948A1
公开(公告)日:2016-01-21
申请号:US14745159
申请日:2015-06-19
Applicant: Marian C. Bryan , Bryan Chan , Emily Hanan , Timothy Heffron , Hans Purkey , Richard Leonard Elliott , Robert Heald , Jamie Knight , Michael Lainchbury , Eileen M. Seward
Inventor: Marian C. Bryan , Bryan Chan , Emily Hanan , Timothy Heffron , Hans Purkey , Richard Leonard Elliott , Robert Heald , Jamie Knight , Michael Lainchbury , Eileen M. Seward
IPC: C07D471/04 , A61K45/06 , C07D498/10 , A61K31/5355 , A61K31/541 , C07D498/08 , A61K31/538 , C07D491/107 , A61K31/506 , A61K31/5377
CPC classification number: C07D471/04 , A61K31/506 , A61K31/5355 , A61K31/5377 , A61K31/538 , A61K31/541 , A61K45/06 , C07D491/107 , C07D498/08 , C07D498/10 , C07D519/00
Abstract: This invention relates to novel compounds which are inhibitors of T790M containing EGFR mutants, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the prevention or treatment of cancer.
Abstract translation: 本发明涉及作为含有EGFR突变体的T790M抑制剂的新化合物,含有它们的药物组合物,其制备方法及其在治疗中用于预防或治疗癌症的新化合物。